Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ORKA-001 in Participants With Moderate-to-Severe Plaque Psoriasis

NCT07090330 is registered in ClinicalTrials.gov with Oruka Therapeutics, Inc. as lead sponsor.

NCT NCT07090330
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07090330 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ORKA-001 in Participants With Moderate-to-Severe Plaque Psoriasis
Lead sponsor
Oruka Therapeutics, Inc.
Phase
Phase 2
Overall status
Active, not recruiting
Start date
July 18, 2025
Completion date
May 31, 2027
Enrollment
80 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

plaque psoriasis